LDL-C control and statins administration during 1-year follow-up after coronary stent implantation:distance from new Blood Fat Treatment Guideline of America (2013)
ZHAO Bei
LIU Li-feng
LIU Ying-qi
LIU Li
ZHAO Jing-tao
ZHOU Li
XIA Hui-hui
WANG Shou-li
Abstract：Objective To analyze LDL-C control and statins administration during 1-year follow-up after coronary stent implantation, and compared with new Blood Fat Treatment Guideline of America (2013, new guideline). Methods The patients (n=539) underwent coronary stent implantation were chosen from Sept. 2010 to Dec. 2012, and followed up for 1 year for collecting reexamine data including LDL-C level, biochemical indexes and statins administration. Results After treatment for 1 year, there were 373 cases (69.2%) achieved target goal of LDL-C and 166 cases (30.8%) did not according to ACC/AHA guideline (2004). There were 195 cases (36.1%) achieved target goal of LDL-C and 344 cases (63.9%) did not according to new ACC/AHA guideline (2013). Kappa value was-0.047 (P=0.178). The statins were mainly atorvastatin (n=247, 10 mg-80 mg) and rosuvastatin (n=147, 5 mg-20 mg), and others included simuvastatin (n=139, 25.7%, 10 mg-40 mg), fluvastatin (n=2, 40 mg) and pravastatin (n=4, 40 mg). According to treatment intensity of statins in new guideline, there were 21 cases (4.0%) with low-intensity treatment, 512 cases (94.9%) with mid-intensity treatment and 6 cases (1.1%) with high-intensity treatment, and 43 cases were given statins combined probucol. Conclusion The level of LDL-C can not achieve target goal in most patients after coronary stent implantation and statins treatment for 1 year according the new guideline, so whether or not Chinese population is fit to the new guideline needs further study.
Keywords：Coronary heart diseaseStentLow-density lipoprotein-cholesterolStatins
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 577-579,583 )